Kevin C Yao, MD
- ASSISTANT CLINICAL PROFESSOR | Neurosurgery
- Hospital Affiliation
- The Mount Sinai Hospital
MD, Columbia University College of Physicians & Surgeons
Internship, General Surgery
Mount Sinai School of Medicine
Mount Sinai School of Medicine
Fellowship, Neurosurgical Oncology
MD Anderson Cancer Center (Univ of Texas)
Yao K, Komata T, Kondo Y, Kondo S, Germano I. Molecular response of human glioglastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy. J Neurosurg 2003; 98(2): 378 - 384.
Hwang S, Abozed M, Hale A, Eisenberg R, Dvorak T, Yao K, Pfannl R, Mignano J, Zhu J, Price L, Strauss G, Wu J. Adjuvant Gamma Knife radiosurgery following surgical resection of brain metastases: a 9-year retrospective cohort study. J. Neurooncol. 2010; 98(1): 77 - 82.
Yao K, Boriani S, Gokaslan Z, Sundaresan N. En bloc spondylectomy for spinal metastases: a review of techniques. Neurosurgical Focus 2003; 15(5): E6.
Yao KC, Malek AM. Transpedicular N-butyl cyanoacrylate-mediated percutaneous embolization of symptomatic vertebral hemangiomas. Journal of neurosurgery. Spine 2013 May; 18(5).
McGirt M, Chaichana K, Atiba A, Attenello F, Yao K, Jallo G. Resection of intramedullary spinal cord tumors in children: assessment of long-term motor and sensory deficits.. J Neurosurg Pediatrics 2008; 1(1): 63 - 67.
Yao K, McGirt M, Constantini S, Chaichana K, Epstein F, Jallo G. Risk factors for progressive spinal deformity following resection of intramedullary spinal cord tumors in children: an analysis of 161 consecutive cases. J Neurosurg 2007; 107(6): 463 - 468.
McGirt M, Chaichana K, Attenello F, Witham T, Bydon A, Yao K, Jallo G. Spinal deformity after resection of cervical intramedullary spinal cord tumors in children. Childs Nerv Syst 2008; 24(6): 735 - 739.
Riesenburger R, Hwang S, Schirmer C, Zerris V, Wu J, Mahn K, Klimo P, Mignano J, Thompson C, Yao K. Outcomes following single-treatment Gamma Knife surgery for trigeminal neuralgia with a minimum 3-year follow-up. J Neurosurg 2010; 112(4): 766 - 771.
Dvorak T, Finn A, Price L, Mignano J, Fitzek M, Wu J, Yao K. Re-treatment of trigeminal neuralgia with Gamma Knife radiosurgery: is there an appropriate cumulative dose. J Neurosurg 2009; 111(2): 359 - 364.
Riesenburger R, Mahn K, Yao K. Gamma knife radiosurgery for intractable trigeminal neuralgia in the geriatric population. Annals of Longterm Care 2006; 14(12): 21 - 24.
Schirmer C, Chan M, Mignano J, Duker J, Melhus C, Williams L, Wu J, Yao K. Dose De-escalation with Gamma Knife Radiosurgery in the Treatment of Choroidal Melanoma. Int J Radiat Oncol Biol Phys 1 2009; 75(1): 170 - 176.
Joye RP, Williams LB, Chan MD, Witkin AJ, Schirmer CM, Mignano JE, Wazer DE, Yao KC, Wu JK, Duker JS. Local control and results of Leksell Gamma Knife therapy for the treatment of uveal melanoma. Ophthalmic surgery, lasers & imaging retina; 45(2).
Chan MD, Melhus CS, Mignano JE, Do-Dai D, Duker JS, Yao KC. Analysis of visual toxicity after gamma knife radiosurgery for treatment of choroidal melanoma: identification of multiple targets and mechanisms of toxicity. American journal of clinical oncology 2011 Oct; 34(5).
Miele WR, Schirmer CM, Yao KC, Heilman CB. Spontaneous resolution of a Chiari malformation Type I and syrinx after supratentorial craniotomy for excision of a cavernous malformation. Journal of neurosurgery 2012 May; 116(5).
Riesenburger RI, Klimo P, Yao KC. A fourth atlantoaxial joint: an initial description. The spine journal : official journal of the North American Spine Society 2011 Apr; 11(4).
Yang S, Burgin A, Huizenga B, Robertson C, Yao K, Nash H. A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc. Natl. Acad. Sci. USA 1996; 93(21).
Pouliot J, Yao K, Robertson C, Nash H. Yeast Gene for Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes.. Science 1999; 286(5439): 552-555.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Yao is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.